Adagene Announces Poster Presentations of Clinical Data for Two Novel Antibody Programs at ESMO Immuno-Oncology Congress 2021
Go back to Adagene Announces Poster Presentations of Clinical Data for Two Novel Antibody Programs at ESMO Immuno-Oncology Congress 2021(NASDAQ: ADAG) | Delayed: 2.75 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $2.75 | 52 Week High | $ | |||
Open | $2.75 | 52 Week Low | $ | |||
Day High | $2.75 | P/E | N/A | |||
Day Low | $2.75 | EPS | $ | |||
Volume | 50 |